Overview
Centene reported Q3 earnings this morning. Its stock is up 11% at the moment after it beat estimates and raised its 2025 outlook from >$1.75 to >$2.00, driven by favorable Medicaid contract terms.
The ACA business performed in line in Q3, but Centene noted an uptick in utilization in September and expects additional pressure to persist in Q4 ahead of a potential special enrollment period in Open Enrollment given the turmoil around the extension of enhanced subsidies.
All in all, a relatively stable quarter for the business that is likely seeing its stock rebound because it avoided the ACA miss that Molina reported last week.
Earnings Report:
Earnings Call Discussion:
Here’s a rundown of the interesting insights from the earnings call, broken down by key line of business:
Join the Health Tech Nerds Community to access.
Join thousands of other innovators in healthcare accelerating their learning in healthcare.
Join the Health Tech Nerds CommunityA community membership gets you:
- Private Slack Community: Exchange ideas, lessons learned and insights with your peers in real time.
- Exclusive insights & expert content: Access deep dives, case studies, and curated wisdom, plus live sessions with industry leaders.
- Networking made easy: Get curated matches, connect through the member directory, and join or host local meetups.
- Proven tools & resources: Save time with research, templates, and community-sourced solutions.